* Explores the intrinsic conflict between intellectual property rights and the distribution of essential medicines
* Discusses the implications for the health of the world’s poorest nations now that the full product patent requirements for medicines have come into force
* The world’s leading authorities on the subject write from the perspectives of both the 'developed' and the 'developing' world

In developing countries, access to affordable medicines for the
treatment of diseases such as AIDS and malaria remains a matter of
life or death. In Africa, for instance, more than one million children
die each year from malaria alone, a figure which could soon be far
higher with the extension of patent rules for pharmaceuticals.
Previously, access to essential medicines was made possible by the
supply of much cheaper generics, manufactured largely by India;
from this year, however, the availability of these drugs is threatened
as new WTO rules take effect. Halting the spread of malaria and
HIV/AIDS is one of the eight Millennium Goals adopted at the UN
Millennium Summit, which makes this a timely and topical book.
Informed analysis is provided by internationally renowned
contributors who look at the post-2005 world and discuss how action
may be taken to ensure access to medicines is not sacrificed to
corporate attempts to protect business interests.

37.03